Method of producing bispecific molecules by protein...

Details Method of producing bispecific molecules by protein... Method of producing bispecific molecules by protein...

2001-11-01

2008-07-29

Saunders, David A. (Department: 1644)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S388200, C530S388220

Reexamination Certificate

active

07405276

ABSTRACT:
The invention provides methods of using protein trans-splicing for the production of bispecific molecule which has a first antigen recognition portion that binds a C3b-like receptor and a second antigen recognition portion that binds an antigenic molecule present in the circulatory system of a mammal. The invention also provides bispecific molecules produced by protein trans-splicing. The bispecific molecules of the invention can be used for the clearance of pathogenic antigenic molecules from the circulatory system of a mammal. The invention further provides methods of using protein trans-splicing for the production of polyclonal libraries of bispecific molecules, which comprise populations of bispecific molecules with different antigen recognition specificities. Such polyclonal libraries of bispecific molecules can be used for targeting multiple epitopes of a pathogenic antigenic molecule and/or multiple variants of a pathogenic antigenic molecule.

REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4672044 (1987-06-01), Schreiber
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5223409 (1993-06-01), Ladner
patent: 5225539 (1993-07-01), Winter et al.
patent: 5470570 (1995-11-01), Taylor et al.
patent: 5487890 (1996-01-01), Taylor et al.
patent: 5514548 (1996-05-01), Krebber et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5653979 (1997-08-01), Muzykantov et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5821331 (1998-10-01), Hammond et al.
patent: 5843440 (1998-12-01), Pouletty et al.
patent: 5879679 (1999-03-01), Taylor et al.
patent: 5914112 (1999-06-01), Bednar et al.
patent: 5985615 (1999-11-01), Jakobovits et al.
patent: 6054312 (2000-04-01), Larocca et al.
patent: 6057098 (2000-05-01), Buechler et al.
patent: 6060596 (2000-05-01), Lerner et al.
patent: 6488927 (2002-12-01), Muzykantov et al.
patent: 2003/0152563 (2003-08-01), Muzykantov et al.
patent: 2004/0053408 (2004-03-01), Muzykantov et al.
patent: 125023 (1984-11-01), None
patent: 171496 (1986-02-01), None
patent: 171496 (1986-02-01), None
patent: 173494 (1986-03-01), None
patent: 173494 (1986-03-01), None
patent: 184187 (1986-06-01), None
patent: 184187 (1986-06-01), None
patent: 2034323 (1980-06-01), None
patent: WO 87/02671 (1987-05-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO-92/05801 (1992-04-01), None
patent: WO 92/09690 (1992-06-01), None
patent: WO 92/15679 (1992-09-01), None
patent: WO 92/18619 (1992-10-01), None
patent: WO 92/20791 (1992-11-01), None
patent: WO 93/01288 (1993-01-01), None
Scot et al. (1999) Production of cyclic peptides and proteins in vivo. Proc. Natl. Acad. Sci. U S A. vol. 96, No. 24, pp. 13638-13643.
American Heritage College Dictionary: Third Edition. [1997] Houghton Mifflin Co., Boston. p. 59.
Cruse, JM et al. Illustrated Dictionary of Immunology [1995], p. 21.
Air, 1981, “Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus”, Proc. Natl. Acad. Sci. USA 78:7639-7643.
Altura and Hershey, 1968, “RES phagocytic function in trauma and adaptation to experimental shock”, Am. J. Physiol. 215:1414-1419.
Audibert et al., 1981, “Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide”, Nature 289:593-594.
Beachey, 1985, “Protective immunity evoked by synthetic peptides of Streptoccal M proteins”, Adv. Exp. Med. Biol. 185:193-200.
Beidler et al., 1988, Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic Antigen, J. Immunol. 141:4053-4060.
Better et al., 1988, “Escherichia colisecretion of an active chimeric antibody fragment”, Science 240:1041-1043.
Brodeur et al., 1987, “Mouse-human myeloma partners for the production of heterohybridomas”, in:Monoclonal Antibody Production Techniques and Applications, Marcel Dekker, Inc., New York, pp. 51-63.
Bzik et al., 1986, “The nucleotide sequence of the gB glycoprotein gene of HSV-2 and comparison with the corresponding gene of HSV-1”, Virology 155:322-333.
Chang, 2000, “The pharmacological basis of anti-IgE therapy”, Nature Biotechnology 18:157-162.
Co et al., 1991, “Humanized antibodies for antiviral therapy”, Proc. Natl. Acad. Sci. USA 88:2869.
Cole et al., 1985, “The EBV-hybridoma Technique and its Application to Human Lung Cancer”, in:Monoclonal Antibodies and Cancer Therapy, Reisfeld and Sell, eds., Alan R. Liss, Inc., NY, pp. 77-96.
Collins et al., 1984, “Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus”, Proc. Natl. Acad. Sci. USA 81:7683-7687.
Cook et al., 1995, “Photochemically initiated protein splicing”, Angew. Chem. Int. Ed. Engl. 34:1629-1630.
Corvalan and Smith, 1987, “Construction and characterisation of a hybrid—hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids”, Cancer Immunol. Immunother., 24:127-132.
Cruikshank et al., 1997, “A lipidated anti-tat antibody enters living cells and blocks HIV-1 viral replication”, J. Acquired Immune Deficiency Syndromes and Human Retrovirology 14:193-203.
Dalrymple et al., 1981, “Antigenic components of Punta Toro virus”, in:The Replication of Negative Strand Viruses, Bishop and Compans, eds., Elsevier, NY, p. 167-172.
Davis et al., 1991, “Novel structure of therecA locus ofMycobacterium tuberculosisimplies processing of the gene product”, J. Bacteriol. 173:5653-5662.
Davis et al., 1992, “Protein splicing in the maturation ofM. tuberculosisRecA protein: A mechanism for tolerating a novel class of intervening sequence”, Cell 71:201-210.
Deguchi et al., 1999, “Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain drug delivery vector via an extended poly(ethylene glucol) linker”, Bioconjugate Chem. 10:32-37.
Den et al., 1999, “A bidirectional phage display vector for the selection and mass transfer of polyclonal antibody libraries”, J. Immunol. Meth. 222:45-47.
Emini et al., 1983, “Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides”, Nature 304:699.
Ernst et al., 1999, “From IgG monoclonals to IgM-like molecules”, Human Antibodies 9:165-170.
Evans and Xu, 1999, “Intein-mediated protein ligation: Harnessing nature's escape artists”, Biopolymer 51:333-342.
Evans et al., 1999, “The cyclization and polymerization of bacterially expressed proteins using modified self-splicing inteins”, J. Biol. Chem. 274:18359-18363.
Evans et al., 2000, “Proteintrans-splicing and cyclization by a naturally split intein from thednaEgene ofSynechocystisspecies PCC6803”, J. Biol. Chem. 275:9091-9094.
Evans et al., 1999, “Thein vitroligation of bacterially expressed proteins using an intein fromMethanobacterium thermoautotrophicum”, J. Biol Chem. 274:3923-3926.
Ferguson et al., 1995, “Antigen-based heteropolymers. A potential therapy for binding and clearing autoantibodies via erythrocyte CR1”, Arthritis Rheum 38: 190-200.
Foulon et al., 1999, “Preparation and characterization of anti-tenascin monoclonal antibody—streptavidin conjugates for pretargeting applications”, Bioconjugate Chem. 10:867-876.
Fuchs et al., 1991, “Targeting recombinant antibodies to the surface ofEscherichia coli: Fusion to a peptidoglycan associated lipoprotein”, Bio/Technology 9:1369-1372.
Ganem and Varmus, 1987, “The molecular biology of the hepatitis B viruses&#

Affiliated with

Also associated with

Rating

Method of producing bispecific molecules by protein... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of producing bispecific molecules by protein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing bispecific molecules by protein... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3970633